Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Avara Acquires AstraZeneca UK Manufacturing Facility | Contract Pharma

What are you searching for?

Sign in
Breaking News

Avara Acquires AstraZeneca UK Manufacturing Facility

Will continue to manufacture critical AstraZeneca products on a contract basis

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Avara Pharmaceutical Services acquired AstraZeneca’s manufacturing facility located in Avlon, Avonmouth, England.

Under the terms of the agreement, about 210 Avlon employees will remain employed at the site, and the plant will continue to manufacture critical AstraZeneca pharmaceutical products on a contract basis. AstraZeneca will continue to source a stable supply of high-quality products from the facility under the new ownership of Avara following the acquisition.

“We are excited to have the Avlon organization join the Avara team and to add this significant capability to the Avara company,” said Tim Tyson, chairman and chief executive officer, Avara. “We are honored to have the strategic partnership with AstraZeneca and to manufacture key products for them. We are excited to be able to transition this AstraZeneca center of technical excellence to a worldwide pharmaceutical services center of excellence. This exceptional facility will be the fifth site in our global network with other facilities in the U.S., Puerto Rico, Ireland and now the UK.

“We thank the AstraZeneca employees in Avlon for their dedication, and we wish them well as they transition to Avara,” said Marc Jones, executive vice president, supply, EMEA, AstraZeneca. “We have confidence that Avara is the right company to oversee the continuing supply of the AstraZeneca products that are made at the facility, as well as to build a long-term sustainable future for the site. We look forward to partnering with Avara as the new owner of the site to ensure the continuous supply of our products for the patients who need them.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics